| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated treatment with rtPA for pulmonary embolism induced circulatory arrest
|
Bakkum, M.J.
|
|
|
203 |
C |
p. 74-80
|
artikel
|
| 2 |
Accuracy of the functional, flow cytometer-based Emo-Test HIT Confirm® for the diagnosis of heparin-induced thrombocytopenia
|
Brodard, Justine
|
|
|
203 |
C |
p. 22-26
|
artikel
|
| 3 |
A comparison of natural language processing to ICD-10 codes for identification and characterization of pulmonary embolism
|
Johnson, Stacy A.
|
|
|
203 |
C |
p. 190-195
|
artikel
|
| 4 |
Anti-Xa levels in critically ill children receiving enoxaparin for venothromboembolism prophylaxis
|
Marshall, Amanda M.
|
|
|
203 |
C |
p. 117-120
|
artikel
|
| 5 |
Associations of NETs with inflammatory risk and atherosclerotic severity in ST-segment elevation myocardial infarction
|
Zhou, Jinying
|
|
|
203 |
C |
p. 5-11
|
artikel
|
| 6 |
Coagulation profile in newly diagnosed T-cell acute lymphoblastic leukemia
|
Li, Xue-Ying
|
|
|
203 |
C |
p. 69-71
|
artikel
|
| 7 |
Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy
|
Rhoades, Ruben
|
|
|
203 |
C |
p. 1-4
|
artikel
|
| 8 |
Comparison of temporary interruption with continuation of direct oral anticoagulants for low bleeding risk procedures
|
Sheikh, Muhammad Adil
|
|
|
203 |
C |
p. 27-32
|
artikel
|
| 9 |
Deciphered coagulation profile to diagnose the antiphospholipid syndrome using artificial intelligence
|
de Laat - Kremers, Romy M.W.
|
|
|
203 |
C |
p. 142-151
|
artikel
|
| 10 |
Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study
|
Rahme, Elham
|
|
|
203 |
C |
p. 121-130
|
artikel
|
| 11 |
Early ADAMTS13 testing associates with pre-eclampsia occurrence in antiphospholipid syndrome
|
Bitsadze, Viktoria
|
|
|
203 |
C |
p. 101-109
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
203 |
C |
p. IFC
|
artikel
|
| 13 |
Effect of α2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism
|
Baráth, Barbara
|
|
|
203 |
C |
p. 110-116
|
artikel
|
| 14 |
Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: A systematic review and meta-analysis of cohort studies
|
Noumegni, Steve Raoul
|
|
|
203 |
C |
p. 172-185
|
artikel
|
| 15 |
Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination
|
Douxfils, Jonathan
|
|
|
203 |
C |
p. 163-171
|
artikel
|
| 16 |
Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region
|
Arribalzaga, Karmele
|
|
|
203 |
C |
p. 93-100
|
artikel
|
| 17 |
Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients
|
Preti, Paola S.
|
|
|
203 |
C |
p. 33-35
|
artikel
|
| 18 |
In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis
|
Mumoli, Nicola
|
|
|
203 |
C |
p. 82-84
|
artikel
|
| 19 |
Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis
|
Moll, Matthew
|
|
|
203 |
C |
p. 57-60
|
artikel
|
| 20 |
Management of anticoagulation associated reproductive tract bleeding in adolescent and young adult females - Results of a multinational survey
|
Rajpurkar, Madhvi
|
|
|
203 |
C |
p. 61-68
|
artikel
|
| 21 |
Multiparameter microfluidics assay of thrombus formation reveals increased sensitivity to contraction and antiplatelet agents at physiological temperature
|
Herfs, Linda
|
|
|
203 |
C |
p. 46-56
|
artikel
|
| 22 |
Myeloperoxidase has no effect on the low procoagulant activity of silica-free DNA
|
Beckmann, Lennart
|
|
|
203 |
C |
p. 36-45
|
artikel
|
| 23 |
Not all patent foramen ovales are alike!
|
Rigatelli, Gianluca
|
|
|
203 |
C |
p. 81
|
artikel
|
| 24 |
Ovarian vein thrombosis after gynecological malignant tumor surgery with adnexectomy: Clinical features and outcomes
|
Takahashi, Yoshifumi
|
|
|
203 |
C |
p. 90-92
|
artikel
|
| 25 |
Platelet hyperactivation and hyporesponsiveness at diagnosis in multiple myeloma persists during treatment initiation
|
O'Sullivan, Leanne R.
|
|
|
203 |
C |
p. 186-189
|
artikel
|
| 26 |
Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study
|
Ageno, Walter
|
|
|
203 |
C |
p. 138-141
|
artikel
|
| 27 |
Prothrombotic disorders in non-cirrhotic, non-tumoral portal vein thrombosis
|
Mamad, Hassane
|
|
|
203 |
C |
p. 152-154
|
artikel
|
| 28 |
Recombinant human DNase I for the treatment of cancer-associated thrombosis: A pre-clinical study
|
Várady, Carolina B.S.
|
|
|
203 |
C |
p. 131-137
|
artikel
|
| 29 |
The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE
|
Goto, Shinya
|
|
|
203 |
C |
p. 155-162
|
artikel
|
| 30 |
Therapeutic anticoagulation in COVID-19 patients
|
Lemos, Anna Cristina Bertoldi
|
|
|
203 |
C |
p. 72-73
|
artikel
|
| 31 |
Therapeutic quality control in a regional thrombosis center: The effect of changing the target intensity of anticoagulation with vitamin K antagonists
|
van’t Land, Ron P.
|
|
|
203 |
C |
p. 85-89
|
artikel
|
| 32 |
Thrombosis and thrombocytopenia in antiphospholipid syndrome: their association with mean platelet volume and hematological ratios
|
Llorente-Chávez, Amaya
|
|
|
203 |
C |
p. 12-17
|
artikel
|
| 33 |
Time in therapeutic range is lower in women than in men and is not explained by differences in age or comorbidity
|
Avarello, Ilaria
|
|
|
203 |
C |
p. 18-21
|
artikel
|
Tijdschrift beschrijving